HIV. HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
Conditions
Interventions
Intervention group: A Perl of 50,000 units of vitamin D3 was orally administered per month. Then, three and six months after the intervention, the questionnaire was again filled up for the complete re
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age older than 18 years Non-pregnant women Intervals of at least 6 months since the start of the last regimen Not taking vitamin supplements at least three months before the start of the study No diseases and acute problems preventing intervention by taking vitamin D3 Lack of psychological illnesses and willingness to cooperate in this research project
Exclusion criteria
Exclusion criteria: Modifying the antiretroviral therapy during the study Getting pregnancy in female patients The absence of referral patients for monthly supplementation of vitamin D3 even for one month The occurrence of any illness or specific problem during the conduct of the research People with sarcoidosis, hyperparathyroidism, kidney disease and histoplasmosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD4 Cells Count. Timepoint: Before intervention, three and six months after intervention. Method of measurement: Blood Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Blood Count. Timepoint: Before intervention, three and six months after the intervention. Method of measurement: Blood Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Haghighatdana
Shahid Beheshti University of Medical Sciences
Outcome results
None listed